L&G Pharma Breakthrough UCITS ETF (LON:BIGT)
1,036.00
+1.00 (0.10%)
Apr 2, 2026, 4:28 PM GMT
LON:BIGT Holdings Information
LON:BIGT is an equity ETF with a total of 42 individual holdings. The top holdings are Sarepta Therapeutics stock at 3.40%, United Therapeutics at 3.37%, InnoCare Pharma at 3.15%, BioCryst Pharmaceuticals at 3.09%, and Kyowa Kirin at 3.08%.
Total Holdings
42
Top 10 Percentage
30.62%
Asset Class
Equity
ETF Category
Health Care
Assets
14.18M
PE Ratio
17.88
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | SRPT | Sarepta Therapeutics, Inc. | 3.40% |
| 2 | UTHR | United Therapeutics Corporation | 3.37% |
| 3 | INCPF | InnoCare Pharma Ltd | 3.15% |
| 4 | BCRX | BioCryst Pharmaceuticals, Inc. | 3.09% |
| 5 | TYO: 4151 | Kyowa Kirin Co., Ltd. | 3.08% |
| 6 | AGIO | Agios Pharmaceuticals, Inc. | 2.96% |
| 7 | BME: PHM | Pharma Mar, S.A. | 2.92% |
| 8 | BBIO | BridgeBio Pharma, Inc. | 2.91% |
| 9 | AMS: PHARM | Pharming Group N.V. | 2.88% |
| 10 | PTCT | PTC Therapeutics, Inc. | 2.87% |
| 11 | TYO: 4516 | Nippon Shinyaku Co., Ltd. | 2.85% |
| 12 | RPRX | Royalty Pharma plc | 2.80% |
| 13 | MIRM | Mirum Pharmaceuticals, Inc. | 2.79% |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 2.79% |
| 15 | TVTX | Travere Therapeutics, Inc. | 2.78% |
| 16 | XNCR | Xencor, Inc. | 2.75% |
| 17 | TYO: 4523 | Eisai Co., Ltd. | 2.72% |
| 18 | SWX: BSLN | Basilea Pharmaceutica AG | 2.70% |
| 19 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.70% |
| 20 | STO: SOBI | Swedish Orphan Biovitrum AB (publ) | 2.70% |
| 21 | ARGX | argenx SE | 2.69% |
| 22 | IONS | Ionis Pharmaceuticals, Inc. | 2.69% |
| 23 | ZVRA | Zevra Therapeutics, Inc. | 2.68% |
| 24 | VRTX | Vertex Pharmaceuticals Incorporated | 2.66% |
| 25 | CPH: GMAB | Genmab A/S | 2.65% |
As of Mar 31, 2026